Celsion Corporation Gains 28.94%
Fri 22 May 20 at 05:30 PM
Celsion Corporation (CLSN:NASDAQ) soared at $3.03, representing a gain of 28.9%. On Thu 21 May 20, CLSN:NASDAQ hit a New 2-Week High of $2.35. The stock appeared on our News Catalysts scanner on Mon 18 May 20 at 01:11 PM in the 'INVESTOR UPDATE' category. From Thu 07 May 20, the stock recorded 70.00% Up Days and 72.73% Green Days
About Celsion Corporation (CLSN:NASDAQ)
Celsion Corp is a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.
Top 10 Gainers:
- Yunhong International (ZGYH:NASDAQ), 100%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 91.34%
- XpresSpa Group, Inc. (XSPA:NASDAQ), 70.21%
- Sundial Growers Inc. (SNDL:NASDAQ), 39.69%
- Renren Inc. (RENN:NYSE), 38.03%
- Genesis Healthcare, Inc. (GEN:NYSE), 35.06%
- Mitcham Industries, Inc. (MIND:NASDAQ), 32.03%
- Celsion Corporation (CLSN:NASDAQ), 28.94%
- Xeris Pharmaceuticals, Inc. (XERS:NASDAQ), 28.04%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 27.45%